Abstract
Enterolactone (EL) is a gut microbe metabolite of the flaxseed lignan secoisolariciresinol diglucoside (SDG). Studies suggest a correlation between EL systemic levels and protective effects against cancer and cardiovascular disease. EL's oral bioavailability is low and highly variable due to extensive first-pass metabolism. To better understand the contribution of liver and intestine to first-pass glucuronidation we conducted an in vitro enzyme kinetic analysis of EL glucuronidation in liver and intestinal microsomes from both human and rat. An intrinsic clearance (CLint) value was calculated using the substrate depletion approach. In addition to monitoring substrate depletion, HPLC analysis allowed detection of EL glucuronides which were further substantiated by LC-MS/MS. EL monoglucuronide was identified in human and rat liver and intestinal microsomes. Enzyme kinetic studies indicated the extent of hepatic microsomal glucuronidation exceeded intestinal glucuronidation in both human and rat, while the human liver CLint value was slightly higher than that of rat liver. The CLint value generated in human intestinal microsomes was only one third of human liver, whereas the CLint of rat jejunum or colon was one-twentieth of rat liver suggesting the human intestine makes a greater contribution to EL glucuronidation than rat intestine. Our results suggest that both liver and intestine contribute to EL glucuronidation and the human intestine may exert a greater influence on the first-pass glucuronidation of EL than rat intestine. The rat might underestimate the extent of intestinal metabolism of EL relative to human.
Keywords: Enterolactone, flaxseed, glucuronidation, intestine, liver, lignan.
The Natural Products Journal
Title:The Comparison of Rat and Human Intestinal and Hepatic Glucuronidation of Enterolactone Derived from Flaxseed Lignans
Volume: 3 Issue: 3
Author(s): Chaojie Lin, Ed S Krol and Jane Alcorn
Affiliation:
Keywords: Enterolactone, flaxseed, glucuronidation, intestine, liver, lignan.
Abstract: Enterolactone (EL) is a gut microbe metabolite of the flaxseed lignan secoisolariciresinol diglucoside (SDG). Studies suggest a correlation between EL systemic levels and protective effects against cancer and cardiovascular disease. EL's oral bioavailability is low and highly variable due to extensive first-pass metabolism. To better understand the contribution of liver and intestine to first-pass glucuronidation we conducted an in vitro enzyme kinetic analysis of EL glucuronidation in liver and intestinal microsomes from both human and rat. An intrinsic clearance (CLint) value was calculated using the substrate depletion approach. In addition to monitoring substrate depletion, HPLC analysis allowed detection of EL glucuronides which were further substantiated by LC-MS/MS. EL monoglucuronide was identified in human and rat liver and intestinal microsomes. Enzyme kinetic studies indicated the extent of hepatic microsomal glucuronidation exceeded intestinal glucuronidation in both human and rat, while the human liver CLint value was slightly higher than that of rat liver. The CLint value generated in human intestinal microsomes was only one third of human liver, whereas the CLint of rat jejunum or colon was one-twentieth of rat liver suggesting the human intestine makes a greater contribution to EL glucuronidation than rat intestine. Our results suggest that both liver and intestine contribute to EL glucuronidation and the human intestine may exert a greater influence on the first-pass glucuronidation of EL than rat intestine. The rat might underestimate the extent of intestinal metabolism of EL relative to human.
Export Options
About this article
Cite this article as:
Lin Chaojie, Krol S Ed and Alcorn Jane, The Comparison of Rat and Human Intestinal and Hepatic Glucuronidation of Enterolactone Derived from Flaxseed Lignans, The Natural Products Journal 2013; 3 (3) . https://dx.doi.org/10.2174/2210315511303030001
DOI https://dx.doi.org/10.2174/2210315511303030001 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Radix Astragali (Astragalus): Latest Advancements and Trends in Chemistry, Analysis, Pharmacology and Pharmacokinetics
Current Organic Chemistry Targeting Dyslipidemia in the Metabolic Syndrome: An Update
Current Vascular Pharmacology A Journey into the World of Targeted Therapy: A Review of Gene Therapy, Stem Cell Therapy, and Cell Reprogramming in Cardiovascular Medicine
Recent Patents on Regenerative Medicine Chronic Hypoxia Potentiates Age-Related Oxidative Imbalance in Brain Vessels and Synaptosomes
Current Neurovascular Research Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Endothelial Cells Facilitate Cell-Based Cardiac Repair: Progress and Challenge
Current Stem Cell Research & Therapy Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology The Pleiotropic Effects of ARB in Vascular Endothelial Progenitor Cells
Current Vascular Pharmacology Long Term Cardiovascular Risk in Women
Vascular Disease Prevention (Discontinued) Prognostic Relevance of Metabolic Approach in Patients with Heart Failure
Current Pharmaceutical Design Anti-Inflammatory Activity of Polysaccharide Fraction of Curcuma longa Extract (NR-INF-02)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Psychotropics and Methadone in Acquired Long QT Syndrome
Current Psychopharmacology Are Carbonic Anhydrase Inhibitors Suitable for Obtaining Antiobesity Drugs ?
Current Pharmaceutical Design Discharge Interventions and Modifiable Risk Factors for Preventing Hospital Readmissions in Children with Medical Complexity
Reviews on Recent Clinical Trials Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
Infectious Disorders - Drug Targets The Role of Statins in the Activation of Heme Oxygenase-1 in Cardiovascular Diseases
Current Drug Targets Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology Metronidazole Loaded Polycaprolactone-Carbopol Blends Based Biodegradable Intrapocket Dental Film for Local Treatment of Periodontitis
Drug Delivery Letters Orthotopic Heart Transplantation in Patients with Univentricular Physiology
Current Cardiology Reviews Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry